Patients&rsquo; Preferences for Attributes of Oral vs Injectable Androgen Deprivation Therapy in Prostate Cancer: A&nbsp;Discrete Choice Experiment

Sean P Collins,1 Agnes Hong,2 Brett Hauber,2 Scott C Flanders,3 Oliver Will,4 Martine C Maculaitis,4 Sergio C Gatoulis,2 Marty Chakoian,5 Jared Thorley6 1Department of Radiation Medicine, Georgetown University; MedStar Georgetown University Hospital, Washington, DC, USA; 2Pfizer Inc., New York, NY,...

Full description

Bibliographic Details
Published in:	Patient Preference and Adherence
Main Authors:	Collins SP, Hong A, Hauber B, Flanders SC, Will O, Maculaitis MC, Gatoulis SC, Chakoian M, Thorley J
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-05-01
Subjects:	mode of administration patient preferences shared decision-making gonadotropin-releasing hormone agonists gonadotropin-releasing hormone antagonists testosterone recovery
Online Access:	https://www.dovepress.com/patients-preferences-for-attributes-of-oral-vs-injectable-androgen-dep-peer-reviewed-fulltext-article-PPA

Similar Items

Impact of Androgen Deprivation Therapy on Cardiovascular Outcomes in Prostate Cancer
by: Laurence Klotz, et al.
Published: (2022-07-01)

Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies
by: Carol M. MacLean, et al.
Published: (2023-03-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

Effect of gonadotropin-releasing hormone agonist on ES-2 ovarian cancer cells
by: Kuan-Hao Tsui, et al.
Published: (2014-03-01)

Importance of bone assessment and prevention of osteoporotic fracture in patients with prostate cancer in the gonadotropic hormone analogues use
by: Bruno Lopes Cançado, et al.

Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China
by: Jingwei Yang, et al.
Published: (2021-08-01)

Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy
by: Wei-Min Liu, et al.
Published: (2013-03-01)

Comparison of Machine Learning Models for Long-Term Recurrence of Endometriosis Treated by Laparoscopy Combined With GnRHa
by: Ke Zhou, et al.
Published: (2025-09-01)

ENDOMETRIOSIS AND FERTILITY. KEY MOMENT OF TREATMENT
by: S. A. Gasparyan, et al.
Published: (2016-06-01)

Supplementation with human menopausal gonadotropin in the gonadotropin-releasing hormone antagonist cycles of women with high AMH: Pregnancy outcomes and serial hormone levels
by: Liang-Hsuan Chen, et al.
Published: (2021-07-01)

Adding human chorionic gonadotropin to frozen-thawed embryo transfer cycles pretreated with GnRH-a improves clinical pregnancy rates: a retrospective study
by: Lingna Peng, et al.
Published: (2025-12-01)

Effects of GnRH agonist immunization on vaginal electrical resistance, FSH, LH, and ovaries in prepubertal female sheep
by: S. Wei, et al.
Published: (2013-09-01)

To compare the effect of GnRH agonist versus human chorionic gonadotropin (HCG) trigger on clinical pregnancy rate in intrauterine insemination cycle
by: Rashmi Sharma, et al.
Published: (2021-01-01)

‌The‌‎ ‎‌effects‌‎ ‎‌of‌‎ ‎‌incremental‌‎ ‎‌aerobic‌‎ ‎‌training‌‎ ‎‌and‌‎ ‎‌electrical‌‎ ‎‌stimulation‌‎ ‎‌on‌‎ ‎‌sexual‌‎ ‎‌biomarkers‌‎ ‎‌in‌‎ ‎‌infarcted‌‎ ‎‌rats‌
by: Mohammad‏‎ Malekipooya, et al.
Published: (2024-12-01)

Mating-induced increase in Kiss1 mRNA expression in the anteroventral periventricular nucleus prior to an increase in LH and testosterone release in male rats
by: Youki WATANABE, et al.
Published: (2020-09-01)

Use of a Gonadotropin-Releasing Hormone Agonist to Manage Perimenopausal Women With Symptomatic Uterine Myomas
by: Peng-Hui Wang, et al.
Published: (2009-06-01)

Vaginal Expulsion of a Submucosal Myoma During Treatment with Long-Acting Gonadotropin-Releasing Hormone Agonist
by: Lily Wen, et al.
Published: (2006-06-01)

GnRH agonist pretreatment in hormonal endometrial preparation: a comparison of two protocols for frozen embryo transfer outcomes
by: Xi Yi, et al.
Published: (2025-10-01)

Angiomyxoma of the pelvis in women. Clinical cases
by: E. V. Slukhanchuk, et al.
Published: (2021-11-01)

DIFFERENTIAL APPROACH TO ADENOMYOSIS TREATMENT
by: I. S. Sidorova, et al.
Published: (2016-09-01)

Real-World Safety and Effectiveness of Ganirelix for Ovarian Stimulation in Chinese Women: A Multicenter, Prospective, Single-Arm, Observational Study
by: Jia Li, et al.
Published: (2025-01-01)

Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology
by: Darren M. C. Poon, et al.
Published: (2024-01-01)

A Case for the Use of Combined Hormonal Therapy for Aggressive Angiomyxoma: Complete Response to Goserelin and Letrozole Following Incomplete Surgical Resection
by: George Mallat, et al.
Published: (2025-09-01)

DEGARELIX ROLE AND PLACE IN THE COMBINED TREATMENT OF PATIENTS WITH PROSTATE CANCER IN COMBINATION WITH CONCURRENT RADIOTHERAPY
by: A. Y. Pavlov, et al.
Published: (2016-02-01)

TUMORAL AND NON TUMORAL PITUITARY LESIONS AND REPRODUCTIVE SYSTEM
by: I. A. Ilovayskaya
Published: (2012-05-01)

Does dual trigger improve euploidy rate in normoresponder? A cross-sectional study
by: Sule Yildirim Kopuk, et al.
Published: (2023-05-01)

Gonadotropin releasing hormone antagonist protocol brings about more available embryos than agonist long protocol
by: ZHAO Shan-ke, FU Yao, CHU Da-peng, FU Lei, HAN Shuo, BAI Xue-yan, LI Yuan, ZHOU Wen-hui
Published: (2022-03-01)

Palmitic acid-modified GnRH-Th epitope peptide immunocastration vaccine (W/O/W adjuvant) can effectively ensure the castration and reduce the smelly smell in boars
by: Huayi Gao, et al.
Published: (2023-04-01)

Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?
by: Amar Ramachandran, et al.
Published: (2014-01-01)

Ovarian Cyst Formation Following Gonadotropin-Releasing Hormone-Agonist Administration Decreases the Oocyte Quality in IVF Cycles
by: Muammer Doğan, et al.
Published: (2012-06-01)

Recurrence rates and associated risk factors after conservative surgery for adenomyosis: a retrospective study
by: Keji Lu, et al.
Published: (2024-11-01)

Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial
by: Safa Najafi, et al.
Published: (2023-11-01)

Effects of Secretoneurin and Gonadotropin-Releasing Hormone Agonist on the Spawning of Captive Greater Amberjack (<i>Seriola dumerili</i>)
by: Song Yanlong, et al.
Published: (2022-09-01)

Transcriptome profiling reveals superovulation with the gonadotropin-releasing hormone agonist trigger impaired embryo implantation in mice
by: Meng Li, et al.
Published: (2024-02-01)

Use of Buserelin depot, a gonadotropin-releasing hormone agonist, in the treatment of prostate cancer
by: L. M. Rapoport, et al.
Published: (2014-12-01)

Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database
by: Surrey ES, et al.
Published: (2020-08-01)

Effect of central administration of indomethacin on anandamide-induced GnRH/LH secretion in the hypothalamus of anoestrous ewes
by: Tomaszewska-Zaremba Dorota, et al.
Published: (2024-07-01)

Insulin sensitivity, body composition and bone mineral density after testosterone treatment in transgender youth with and without prior GnRH agonist therapy
by: Natalie J. Nokoff, et al.
Published: (2024-06-01)

Targeted differential monochromatic lighting improves broiler breeder reproductive performance
by: Sagi Zaguri, et al.
Published: (2020-07-01)

Dual trigger for final oocyte maturation in expected normal responders with a high immature oocyte rate: a randomized controlled trial
by: Meng-Han Yan, et al.
Published: (2023-10-01)